Cell and Gene Manufacturing and Logistics

  1. Rapidly Create Closed System Assemblies For A Customized Configuration 4/28/2025

    Corning Configurable Assemblies utilize an array of proven Corning vessels and pre-qualified components to create a finished product— a unique design—that precisely aligns with your requirements. Our streamlined implementation process ensures short lead times.

  2. Corning® CellCube® System 4/28/2025

    The Corning CellCube system provides a compact, perfusion-based method for the mass culture of attachment-dependent cells. CellCube modules consist of a series of 10, 25, or 100 parallel, polystyrene plates joined to create thin, sealed laminar flow spaces between adjacent plates.

  3. A Checklist For Mechanism-Based Potency Testing In Cell Therapy 4/25/2025

    New research concludes that potency cannot be decoupled from a product's mechanism of action because surrogate markers fail to capture functional relevance.

  4. CD34+ HSC LNP Kits 4/24/2025

    Research Use Only (RUO) lipid nanoparticle (LNP) reagents to deliver RNA into hematopoietic stem cells (HSCs) for cell and gene therapy applications.

  5. GenVoy-ILM™ T-Cell Kits For mRNA 4/24/2025

    Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.

  6. Inside The Development Of An AAV8 Production Platform 4/24/2025

    Explore innovative solutions for AAV8 production challenges, which include scalability and purity, as well as learn how a collaboration with CDMO Matica Biotechnology ensures efficient, high-yield gene therapy vector production.

  7. PDG-FDA Town Hall Notes — DSCSA Readiness Is At Hand 4/24/2025

    Data quality and exceptions handling were key discussion points during a March PDG-FDA town hall, where stakeholders shared updates on progress and unfinished work.

  8. Navigating CGT Biotech's Financial Headwinds And The Path Forward 4/24/2025

    Dr. Ali Pashazadeh, Founder of Treehill Partners shares how CGT companies can navigate today’s biotech downturn by embracing integrated strategies, disciplined capital use, and bold leadership willing to rethink traditional models across innovation, manufacturing, and commercialization.

  9. ICH Revises Q1 Guideline, Advancing Stability Testing Standards 4/24/2025

    In April 2025, the International Council for Harmonisation (ICH) released draft ICH Q1: Stability Testing of Drug Substances and Drug Products for public consultation. This new draft guideline represents the first major overhaul of global stability testing standards in over two decades.

  10. Sustainable Manufacturing Through Efficient BioProduction Unit Operations 4/23/2025

    Delve into the critical environmental and economic aspects of bioprocessing. Explore the urgent need to manage the industry’s growing plastic waste issue and a three-pronged approach to address this challenge.